Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-20-009024
Filing Date
2020-08-13
Accepted
2020-08-13 19:40:14
Documents
1
Period of Report
2020-08-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 4125
  Complete submission text file 0001179110-20-009024.txt   5627
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Issuer) CIK: 0001012477 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MATINAS BIOPHARMA HOLDINGS, INC. 1545 ROUTE 206 SOUTH, SUITE 302 BEDMINSTER NJ 07921
Business Address
Ende Eric J (Reporting) CIK: 0001494386 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37977 | Film No.: 201100869